Enliven Therapeutics, Inc.
ELVN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001672619
In the last 90 days, Enliven Therapeutics, Inc. insiders filed 0 open-market purchases and 8 sales; 214 institutions reported holding it in 13F filings for Q2 2026, worth $4.06B in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Enliven Therapeutics, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 38
- +7 vs. Q2 2021
- Shares held
- 15.3M
- +4.39M (+40.2%) vs. Q2 2021
- Total value
- $62.5M
- −$23.8M (−27.6%) vs. Q2 2021
- New holders
- 17
- 11 more added
- Sold out
- 10
- 8 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ELVN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 214 | $4.06B |
| Q1 2026 | 171 | $2.43B |
| Q4 2025 | 126 | $960.9M |
| Q3 2025 | 134 | $1.22B |
| Q2 2025 | 125 | $1.19B |
| Q1 2025 | 122 | $983.9M |
| Q4 2024 | 114 | $1.12B |
| Q3 2024 | 102 | $1.22B |
| Q2 2024 | 93 | $1.13B |
| Q1 2024 | 74 | $780.8M |
| Q4 2023 | 62 | $539.8M |
| Q3 2023 | 61 | $533.8M |
| Q2 2023 | 63 | $797.9M |
| Q1 2023 | 45 | $735.0M |
| Q4 2022 | 36 | $74.7M |
| Q3 2022 | 31 | $18.8M |
| Q2 2022 | 26 | $13.1M |
| Q1 2022 | 31 | $26.2M |
| Q4 2021 | 35 | $33.6M |
| Q3 2021 | 38 | $62.5M |
| Q2 2021 | 31 | $86.3M |
| Q1 2021 | 40 | $92.9M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Enliven Therapeutics, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| OrbiMed Advisors LLC | 4,386,568 | $17.9M | 0.20% | +1,666,666+61.3% | Added |
| NEA Management Company, LLC | 4,017,170 | $16.4M | 0.21% | 00.0% | Unchanged |
| FMR LLC | 2,310,690 | $9.43M | 0.00% | −335,241−12.7% | Reduced |
| Lion Point Capital, LP | 833,333 | $3.40M | 0.90% | +833,333 | New |
| Rock Springs Capital Management LP | 829,102 | $3.38M | 0.07% | +829,102 | New |
| Vanguard Group Inc | 484,904 | $1.98M | 0.00% | +293,493+153.3% | Added |
| Laurion Capital Management LP | 300,000 | $1.22M | 0.02% | +300,000 | New |
| Morgan Stanley | 290,648 | $1.19M | 0.00% | −138,385−32.3% | Reduced |
| Renaissance Technologies LLC | 274,300 | $1.12M | 0.00% | +234,532+589.8% | Added |
| Two Sigma Advisers, LP | 260,600 | $1.06M | 0.00% | +260,600 | New |
| Two Sigma Investments, LP | 249,495 | $1.02M | 0.00% | +249,495 | New |
| Walleye Capital LLC | 167,657 | $684.0K | 0.02% | +167,657 | New |
| Woodline Partners LP | 134,164 | $547.0K | 0.01% | +134,164 | New |
| Bridgeway Capital Management, LLC | 125,200 | $511.0K | 0.01% | +125,200 | New |
| Millennium Management LLC | 103,803 | $424.0K | 0.00% | +68,940+197.7% | Added |
| BlackRock Inc. | 103,095 | $420.0K | 0.00% | +25,421+32.7% | Added |
| D. E. Shaw & Co., Inc. | 61,991 | $253.0K | 0.00% | +61,991 | New |
| Geode Capital Management, LLC | 54,777 | $223.0K | 0.00% | +3,304+6.4% | Added |
| Tudor Investment Corp Et Al | 51,923 | $212.0K | 0.00% | +51,923 | New |
| Walleye Trading LLC | 43,233 | $176.0K | 0.00% | +43,233 | New |
| Goldman Sachs Group Inc | 37,962 | $155.0K | 0.00% | +27,416+260.0% | Added |
| Great Valley Advisor Group, Inc. | 27,411 | $112.0K | 0.01% | −4,800−14.9% | Reduced |
| HRT Financial LP | 23,199 | $94.0K | 0.00% | +1,284+5.9% | Added |
| State Street Corp | 21,198 | $86.0K | 0.00% | 00.0% | Unchanged |
| Trexquant Investment LP | 19,646 | $80.0K | 0.01% | +19,646 | New |
| Bank of New York Mellon Corp | 18,661 | $76.0K | 0.00% | +18,661 | New |
| Occudo Quantitative Strategies LP | 18,422 | $75.0K | 0.01% | +7,926+75.5% | Added |
| Northern Trust Corp | 15,314 | $62.0K | 0.00% | +15,314 | New |
| Cubist Systematic Strategies, LLC | 11,983 | $49.0K | 0.00% | +11,983 | New |
| Advisory Services Network, LLC | 11,680 | $48.0K | 0.00% | −1,000−7.9% | Reduced |
| Susquehanna International Group, LLP | 11,349 | $46.0K | 0.00% | +11,349 | New |
| Bank of America Corp | 9,359 | $38.0K | 0.00% | −6,279−40.2% | Reduced |
| JPMorgan Chase & Co | 8,148 | $33.0K | 0.00% | −1,943−19.3% | Reduced |
| Tower Research Capital LLC (TRC) | 2,116 | $9.00K | 0.00% | +2,110+35,166.7% | Added |
| Federated Hermes, Inc. | 1,676 | $7.00K | 0.00% | +1,676 | New |
| Deutsche Bank AG | 100 | $0 | 0.00% | −21,403−99.5% | Reduced |
| Royal Bank of Canada | 32 | $0 | 0.00% | −1,962−98.4% | Reduced |
| Wells Fargo & Company | 78 | $0 | 0.00% | +48+160.0% | Added |
| Ra Capital Management, L.P. | 0 | $0 | 0.00% | −248,804−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −193,904−100.0% | Sold out |
| Tibra Equities Europe Ltd | 0 | $0 | 0.00% | −37,500−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −31,546−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −18,284−100.0% | Sold out |
| Altfest L J & Co Inc | 0 | $0 | 0.00% | −15,234−100.0% | Sold out |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −13,794−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −2,143−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −64−100.0% | Sold out |
| Panagora Asset Management Inc | 0 | $0 | 0.00% | −116−100.0% | Sold out |